Related Experiment Video
Updated: Jul 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer
Kirsten M Tracy1, Shannon Prior2, Willem T Trowbridge1
1Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT 05405.
Abstract:
Long non-coding RNA (lncRNA)-mediated control of gene expression contributes to regulation of biological processes that include proliferation and phenotype, as well as compromised expression of genes that are functionally linked to cancer initiation and tumor progression. lncRNAs have emerged as novel targets and biomarkers in breast cancer. We have shown that mitotically associated lncRNA MANCR is expressed in triple-negative breast cancer (TNBC) cells and that it serves a critical role in promoting genome stability and survival in aggressive breast cancer cells. Using an siRNA strategy, we selectively depleted BRD2, BRD3, and BRD4, singly and in combination, to establish which bromodomain proteins regulate MANCR expression in TNBC cells. Our findings were confirmed by using in situ hybridization combined with immunofluorescence analysis that revealed BRD4, either alone or with BRD2 and BRD3, can support MANCR regulation of TNBC cells. Here we provide evidence for MANCR-responsive epigenetic control of super enhancers by histone modifications that are required for gene transcription to support cell survival and expression of the epithelial tumor phenotype in triple negative breast cancer cells.
Insights
Long non-coding RNA MANCR is crucial for triple-negative breast cancer (TNBC) cell survival and genome stability. Bromodomain proteins, particularly BRD4, regulate MANCR expression through epigenetic control of super enhancers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Long non-coding RNAs (lncRNAs) regulate gene expression, impacting biological processes like cell proliferation and cancer progression.
- lncRNAs are emerging as significant targets and biomarkers in breast cancer research.
- The lncRNA MANCR is expressed in triple-negative breast cancer (TNBC) and is vital for aggressive cell survival and genome stability.
Purpose of the Study:
- To investigate the role of bromodomain proteins (BRD2, BRD3, BRD4) in regulating the expression of lncRNA MANCR in TNBC cells.
- To elucidate the epigenetic mechanisms underlying MANCR's function in TNBC.
Main Methods:
- Small interfering RNA (siRNA) was used to deplete BRD2, BRD3, and BRD4 in TNBC cells.
- In situ hybridization combined with immunofluorescence analysis was performed to confirm findings.
- Epigenetic analysis focused on histone modifications and super enhancer activity.
Main Results:
- BRD4, individually or with BRD2 and BRD3, was identified as a key regulator of MANCR expression in TNBC cells.
- Evidence suggests MANCR-responsive epigenetic control of super enhancers via histone modifications.
- These modifications are essential for gene transcription supporting TNBC cell survival and the epithelial tumor phenotype.
Conclusions:
- Bromodomain proteins, especially BRD4, play a critical role in regulating MANCR expression in triple-negative breast cancer.
- Epigenetic modifications of super enhancers, mediated by MANCR, are crucial for TNBC cell survival and progression.
- MANCR represents a potential therapeutic target and biomarker for aggressive breast cancers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
X-chromosome...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression at Multiple Steps
Co-activators and Co-repressors
Master Transcription Regulators

